Bristol-Myers Squibb
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker BMY
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2024 | Add 34% | 346,210 | 0.3% |
| Q4 2023 | Add 25% | 259,150 | 0.2% |
| Q3 2023 | Add 34% | 207,405 | 0.2% |
| Q4 2022 | Add 8% | 184,358 | 0.4% |
| Q3 2022 | Add 36% | 171,386 | 0.4% |
| Q2 2020 | Add 36% | 360,027 | 0.6% |
| Q4 2019 | Reduce 6% | 964,463 | 1.1% |
| Q3 2019 | Reduce 19% | 1,025,210 | 0.9% |
| Q2 2019 | Add 37% | 1,260,748 | 0.9% |
| Q1 2019 | Add 282% | 920,159 | 0.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.